143 related articles for article (PubMed ID: 11523411)
21. [Cyclosporin A in aplastic anemia in dogs: first results].
Barth T; Mischke R; Nolte I
Berl Munch Tierarztl Wochenschr; 1997 Feb; 110(2):60-7. PubMed ID: 9139630
[TBL] [Abstract][Full Text] [Related]
22. [A long-term follow-up study of 50 patients with severe aplastic anemia who have survived more than 3 years after immunosuppressive therapy].
He G; Shao Z; Liu H; Zhang Y; Chen G; Li K; Song L; He H; Zhao M; Fu R; Shi J; Bai J; Zhang H; Chu Y; Yang T; Yang C
Zhonghua Xue Ye Xue Za Zhi; 2002 May; 23(5):229-32. PubMed ID: 12133441
[TBL] [Abstract][Full Text] [Related]
23. The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia.
Jiang S; Wang Y; Shi W; Shao Y; Qiao X; Lin J; Kuang H; Xie X
Pediatr Hematol Oncol; 2009; 26(5):313-20. PubMed ID: 19579077
[TBL] [Abstract][Full Text] [Related]
24. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
Alexopoulos E; Papagianni A; Tsamelashvili M; Leontsini M; Memmos D
Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
[TBL] [Abstract][Full Text] [Related]
25. [Apoptosis of bone marrow cells aplastic anemia patients treated with cyclosporin A].
Ren C; Zhang M; Xu C; Zhang T; Peng J; Li W; Wang W
Zhonghua Xue Ye Xue Za Zhi; 2001 Apr; 22(4):189-92. PubMed ID: 11877071
[TBL] [Abstract][Full Text] [Related]
26. Immunosuppressive therapy for acquired severe aplastic anemia (SAA): a prospective comparison of four different regimens.
Zheng Y; Liu Y; Chu Y
Exp Hematol; 2006 Jul; 34(7):826-31. PubMed ID: 16797409
[TBL] [Abstract][Full Text] [Related]
27. Quality of hematologic recovery in patients with aplastic anemia following cyclosporine therapy.
Yamaguchi M; Nakao S; Takamatsu H; Chuhjo T; Shiobara S; Matsuda T
Exp Hematol; 1995 Apr; 23(4):341-6. PubMed ID: 7534714
[TBL] [Abstract][Full Text] [Related]
28. [Incidence and characteristics of complications in aplastic anemia patients treated with antilymphocytic globulin].
Ganapiev AA; Abdulkadyrov KM; Afanas'ev BV
Ter Arkh; 2003; 75(8):68-71. PubMed ID: 14520856
[TBL] [Abstract][Full Text] [Related]
29. [The treatment results in patients with aplastic anemia using different doses of antilymphocyte globulin].
Abdulkadyrov KM; Ganapiev AA; Shilova ER; Popova TI; Rozanova OE; Katsadze IuL
Ter Arkh; 1995; 67(8):51-4. PubMed ID: 7482337
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcome in acquired aplastic anemia treated with an intensified dose schedule of horse antilymphocyte globulin in combination with androgens.
Leleu X; Terriou L; Duhamel A; Moreau AS; Andrieux J; Dupire S; Coiteux V; Berthon C; Micol JB; Guieze R; Facon T; Bauters F
Ann Hematol; 2006 Oct; 85(10):711-6. PubMed ID: 16830141
[TBL] [Abstract][Full Text] [Related]
31. [Clinical implications of combined measurement bone marrow T cells intracellular IFNgamma and HLA-DRB1*1501 measurement in predicting the response to immunosuppressive therapy for aplastic anemia].
Chen Y; Xu CG; Guo NJ; Huang P; Xiao DJ; Ding BT; Ge LF
Zhonghua Nei Ke Za Zhi; 2007 Oct; 46(10):846-9. PubMed ID: 18218241
[TBL] [Abstract][Full Text] [Related]
32. [Clinical study of ciclosporin in patients with aplastic anemia and pure red-cell aplasia].
Kitamura K; Urabe A; Nomura T; Mizoguchi H; Takaku F
Rinsho Ketsueki; 1995 Mar; 36(3):175-84. PubMed ID: 7783321
[TBL] [Abstract][Full Text] [Related]
33. [The impact of immunosuppressive therapy on genetic instabilities of bone marrow hematopoietic cells in patients with aplastic anemia].
Zhang LH; Wang HJ; Zhang L; Zhou K; Yang DL; Yan ZS; Li HQ; Liu QG; Qi JY; Liu Q; Chu YL; Zhang FK
Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):728-32. PubMed ID: 19176006
[TBL] [Abstract][Full Text] [Related]
34. [Acquired aplastic anemia of the adult. Treatment of 2 cases].
Cabrera ME; Pinto D
Rev Med Chil; 2003 Dec; 131(12):1439-43. PubMed ID: 15022408
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of immunosuppressive therapy in the treatment of seronegative hepatitis associated aplastic anemia.
Chen HF; Xu BX; Shen HS; Li ZY; Jin LJ; Tang JQ; Wang J; Zhu JJ; Qin LM; Cui QY; Ren YY; Wu TQ
Drug Des Devel Ther; 2014; 8():1299-305. PubMed ID: 25246771
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of aplastic anemia with cyclosporine, prednisolone and androgens (primary results apropos of 10 cases].
Frikha M; Sahnoun Z; Kaabachi S; Elloumi M; Gargouri J; Dammak J; Zeghal KM; Souissi T
Therapie; 1996; 51(6):627-9. PubMed ID: 9163998
[TBL] [Abstract][Full Text] [Related]
37. Intermittent vs. continuous 1-year cyclosporin use in chronic plaque psoriasis.
Chaidemenos GC; Mourellou O; Avgoustinaki N; Papakonstantinou M; Karakatsanis G; Katsambas A
J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1203-8. PubMed ID: 17894706
[TBL] [Abstract][Full Text] [Related]
38. Management of acquired aplastic anaemia.
Marsh JC
Blood Rev; 2005 May; 19(3):143-51. PubMed ID: 15748962
[TBL] [Abstract][Full Text] [Related]
39. [Effectiveness of immunosuppressive therapy for childhood aplastic anemia and its predictive factors].
Zhao FY; Xu XJ; Song H; Yang SL; Tang YM
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Aug; 14(8):567-70. PubMed ID: 22898273
[TBL] [Abstract][Full Text] [Related]
40. Salvage therapy of refractory severe aplastic anemia by decreasing cyclosporine dose regimen.
Bertrand A; Philippe M; Bertrand Y; Plantaz D; Bleyzac N
Eur J Haematol; 2014 Feb; 92(2):172-6. PubMed ID: 24147892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
